Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 905-287-4 | CAS number: 1638758-52-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- read-across based on grouping of substances (category approach)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- The reproductive toxicity of the individual (o-, m- and p-) cresol isomers has been investigated in three separate two-generation toxicity studies. No effects on fertility were seen in any study at the high dose level of 450 mg/kg bw/d. General toxicity (increased mortality and in clinical signs including hypoactivity, ataxia, twitches, tremors, prostration, gasping, rapid respiration and perioral wetness) were observed at dose levels of 175 and 450 mg/kg bw/d, resulting parental NOAELs of 30 mg/kg bw/d. Reduced pup weight and viability were seen at the highest (and parentally toxic) dose level of 450 mg/kg bw/d, leading to NOAEL values of 175 mg/kg bw/d. OECD 422 screening studies available for xylenol (mixed isomers) and ethylphenol (mixed isomers) both report and absence of effects on fertility and reproductive NOAEL values of 245 mg/kg bw/d. The Category substances therefore consistently demonstrate a lack of reproductive toxicity. Read-across is therefore proposed to the study with xylenol as the closest structural analogue among the Category members.
Developmental toxicity studies in the rat are available for the individual (o-, m- and p-) cresol isomers. Each study identified significant maternal toxicity (mortality, clinical signs, bodyweight deficits) at the high dose level of 450 mg/kg bw/d, resulting in maternal NOAELs of 175 mg/kg bw/d for each isomer. Slight fetotoxicity was observed at 450 mg/kg bw/d for o-cresol (one visceral variation: dilated lateral ventricles of the brain) and for p-cresol (reduced foetal weight, reduced skeletal ossification). There were no foetal effects with m-cresol at any dose level.
Data source
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: TSCA Health Effects Test guidelines for Specific Organ/Tissue Toxicity - Developmental Toxicity (EPA, 1984,1987)
- Deviations:
- no
- GLP compliance:
- yes
- Limit test:
- no
Test material
- Reference substance name:
- Reaction mass of 2,4-xylenol and 2,5-xylenol
- EC Number:
- 905-287-4
- Cas Number:
- 1638758-52-7
- Molecular formula:
- (CH3)2C6H3OH
- IUPAC Name:
- Reaction mass of 2,4-xylenol and 2,5-xylenol
- Test material form:
- solid: bulk
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS- Source: Charles River Breeding labarotory, Kingston, NY- Age at study initiation: 56 days at arrival- Weight at study initiation: 228-231g- Housing: after mating: singly- Diet : ad libitum - Water : ad libitum- Acclimation period: 2 weeksENVIRONMENTAL CONDITIONS- Temperature (°F): 72- Humidity (%): 40 - 60- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:Dosing formulations were prepared by weighing the amount of test chemical into a volumetric flask and diluting to volume with certified corn oil. The resulting solutions were mixed by repeated inversions and stored at room temperature.
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- A standard stock solution (1 mg/ml) was prepared as needed by weighing 50 mg m-cresol into a 50 ml volumetric flask and diluting to volume with propanol. Standards ranging from 10 to 100 ng/ml were prepared by diluting the stock solution with propanol. 10 µl of each standard was injected onto the HPLC. the actual conentration of each dosing solution was calculated from the equitation for the standard curve developed by linear regression.
- Details on mating procedure:
- - Impregnation procedure: cohoused- If cohoused: - M/F ratio per cage: 1:1 - Verification of same strain and source of both sexes: yes- Proof of pregnancy: vaginal plug referred to as day 0 of pregnancy:
- Duration of treatment / exposure:
- day 6 through day 15 of gestation
- Frequency of treatment:
- daily
- Duration of test:
- gd 21 (scheduled sacrifice)
- No. of animals per sex per dose:
- 25 females/ group, 50 control females
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- no further data
Examinations
- Maternal examinations:
- CAGE SIDE OBSERVATIONS: Yes - Time schedule: daily- Cage side observations : mortalityDETAILED CLINICAL OBSERVATIONS: Yes - Time schedule: twice dailyBODY WEIGHT: Yes- Time schedule for examinations: : gd 0, 6, 11, 15, 21FOOD CONSUMPTION Yes - Food consumption for each animal determined throughout gestation gd 0-21WATER CONSUMPTION NoPOST-MORTEM EXAMINATIONS: Yes- Sacrifice on gestation day 21 - Organs examined: body weight, liver, gravid uterine weight, number of corpora lutea, number and status of implantaion sitesOTHER:
- Ovaries and uterine content:
- The ovaries and uterine content was examined after termination: Yes Examinations included:- Gravid uterus weight: Yes - Number of corpora lutea: Yes - Number of implantations: Yes - Number of early resorptions: Yes - Number of late resorptions: Yes
- Fetal examinations:
- - External examinations: Yes: all per litter- Soft tissue examinations: Yes: half per litter- Skeletal examinations: Yes: half per litter- Head examinations: Yes: half per litter
- Statistics:
- Levene's test, ANOVA, t-test with Bonferroni prohabilities, Kruskal-Wallis test, Mann-Whitney U test, Fishers exact test
- Indices:
- no data
- Historical control data:
- no data
Results and discussion
Results: maternal animals
Maternal developmental toxicity
- Details on maternal toxic effects:
- Maternal toxic effects:yesDetails on maternal toxic effects:no mortality,no treatment-related abortions or early delivery, no treatment related lesions in dams at scheduled sacrifice450 mg/kg bw/day (significant canges only)significant reduction in mean maternal body weights:gd 11: 261 g versus 276 g in controlsgd 15: 281 g versus 300 g in controlsreduction in mean weight gain during dosingreduced mean gestational weight gaingd 0-21: 145 g versus 163 g in controls clinical signs of toxicity : predominantly hypoactivity, ataxia, tremors, twitches, prone positioning, audible rtespiration, perioral wetnessreduction inmean food consumptionpretratment period: day 6-9: 15 g versus 21 g of controlstreatment period gd 6-15 : 19 g versus 22 g of controlsrelative (not absolute) liver weight was increased4.9 % versus 4.52 % in controls
Effect levels (maternal animals)
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- ca. 175 mg/kg bw/day
- Basis for effect level:
- other: maternal toxicity
Results (fetuses)
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects:no effectsDetails on embryotoxic / teratogenic effects:no effects
Effect levels (fetuses)
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- 450 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Remarks on result:
- not determinable due to absence of adverse toxic effects
Fetal abnormalities
- Key result
- Abnormalities:
- no effects observed
Overall developmental toxicity
- Key result
- Developmental effects observed:
- no
Any other information on results incl. tables
RS-Freetext:
maternal toxicity: no deaths, no abortions or early deliveries
450 mg/kg:
significant reduced food consumption, reduced maternal body weights and weight gain during dosing period; reduced gestational weight gain (day 0-21);
clinical signs of toxicity: hypoactivity, ataxia, tremors, audible respiration, perioral wetness; increased relative but not absolute liver weights no embryotoxicity or teratogenicity was observed at any dosage level
Applicant's summary and conclusion
- Executive summary:
Developmental toxicity study according to TSCA Health Effects Test guidelines for Specific Organ/Tissue Toxicity - Developmental Toxicity (EPA, 1984,1987):
Administration of m-cresol by gavage to time-pregnant-Sprague Dawley rats during organogenesis at 0.0, 30, 175, 450 mg/kg bw/d resulted in maternal toxicity at 450 mg/kg bw/day including significant reduction in periodic maternal body weights and weight gain during the dosing period in addition with clinical signs of toxicity (NOAEL (maternal toxicity) 175 mg/kg bw/d). m-Cresol did not induce fetotoxicity or malformations at any dose level tested. (NOAEL (developmental toxicity) >450 mg/kg bw).
The above results are suitable to be used for read across for Reaction mass of 2,4-xylenol and 2,5-xylenol, due to the category being based on structural similarity and comparable physicochemical properties, leading to similar (eco)toxicological properties.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.